OPEXA THERAPEUTICS OPXA (NASDAQ) $ 1.60 Change: -0.11 -6.87% | Volume: 50,556

OPEXA THERAPEUT - Fundamental Profile

Company Information

Ticker Symbol: OPXA
Exchange: NASD
Contact Info: 2635 N Crescent Ridge Drive The Woodlands TX 77381 281-272-9331
CEO/President:
Industry: Medical - Biomedical / Standard Industry Code: 2834
Description: Opexa Therapeutics, Inc. develops and commercializes cell therapies to treat autoimmune diseases such as MS, rheumatoid arthritis, and diabetes. The Company is focused on autologous cellular therapy applications of its proprietary T-cell and stem cell therapies. The Company\'s lead product, Tovaxin, a T-cell therapy for multiple sclerosis is in Phase IIb trials. The Company holds the exclusive worldwide license for adult multipotent stem cells derived from mononuclear cells of peripheral blood. The technology allows large quantities of monocyte derived stem cells to be produced efficiently for use in autologous therapy, thus circumventing the threat of rejection. The Company is in preclinical development for type one diabetes.

Share Information

Shares Outstanding: 6,700 (000) Market Value: 16,420 ($000)
Percentage of Inst.Shareholders: 27.14% Number of Inst.Shareholders: N/A%
Last Quarter Sales: 0.00 ($Mil.) Last Quarter Net Income: -3.10 ($Mil.)
Last Quarter EPS: -0.37 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: -2.26
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +42.90 63.80
GILEAD SCIENCES +50.60 56.77
GENENTECH INC +46.50 96.95
BIOGEN IDEC INC -10.50 49.90
CELGENE CP +34.90 75.15